Sio Gene Therapies Inc Quick Ratio (SIOX) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Sio Gene Therapies Inc   (NASDAQ: SIOX)

Sio Gene Therapies Inc 's Quick Ratio

SIOX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Sio Gene Therapies Inc 's Cash & cash equivalent, this led to improvement in Sio Gene Therapies Inc 's Quick Ratio to 21.43, above Sio Gene Therapies Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Quick Ratio than Sio Gene Therapies Inc in third quarter 2022. While Quick Ratio total ranking has improved so far during the Q3 2022 to 174, from total ranking in the second quarter 2022 at 403.

Explain Quick Ratio?
How much Cash & cash equivalents SIOX´s has?
What are SIOX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SIOX Quick Ratio (Dec 31 2022)
Q3		 (Sep 30 2022)
Q2		 (Jun 30 2022)
Q1		 (Mar 31 2022)
Q4		 (Dec 31 2021)
Q3
Y / Y Current Liabilities Change -85.78 % -53.14 % 20.46 % 26.95 % 69.16 %
Y / Y Cash & cash equivalent Change -43.69 % -50.97 % -50.65 % -46.44 % -8.04 %
Quick Ratio MRQ 21.43 10.32 5.99 4.63 5.41
SIOX's Total Ranking # 174 # 403 # 396 # 567 # 766
Seq. Current Liabilities Change -55.45 % -47.21 % -33.56 % -9.03 % 46.86 %
Seq. Cash & cash equivalent Change -7.5 % -8.96 % -14.06 % -22.2 % -19.46 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 62
Overall Market # 174


Quick Ratio Statistics
High Average Low
72.46 11.48 0.91
(Jun 30 2015)   (Dec 31 2019)




Financial Statements
Sio Gene Therapies Inc 's Current Liabilities $ 2 Millions Visit SIOX's Balance sheet
Sio Gene Therapies Inc 's Cash & cash equivalent $ 46 Millions Visit SIOX's Balance sheet
Source of SIOX's Sales Visit SIOX's Sales by Geography


Cumulative Sio Gene Therapies Inc 's Quick Ratio

SIOX's Quick Ratio for the trailling 12 Months

SIOX Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -31.87 % 13.76 % 29.2 % 10.87 % -30.8 %
Y / Y Cash & cash equivalent TTM Growth -48.14 % -40.51 % -20.96 % 9.67 % 43.36 %
Quick Ratio TTM 7.17 5.84 6.25 7.65 9.42
Total Ranking TTM # 4204 # 532 # 3682 # 4180 # 4090
Seq. Current Liabilities TTM Growth -30.28 % -11.33 % 3.32 % 6.66 % 16.42 %
Seq. Cash & cash equivalent TTM Growth -14.3 % -17.16 % -15.69 % -13.36 % -1.7 %

Quick ratio ranking by company, industry and sector >> Back to SIOX Financial Strength Comparisons >> Go to Compare SIOX Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Sio Gene Therapies Inc 's average Cash & cash equivalent, this led to increase in in Sio Gene Therapies Inc 's Quick Ratio to 7.17, above SIOX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 566 other companies have achieved higher Quick Ratio than Sio Gene Therapies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 532 to 4204.

Explain Quick Ratio?
How much Cash & cash equivalents SIOX´s has?
What are SIOX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 567
Healthcare Sector # 1131
Within the Market # 4204


trailing twelve months Quick Ratio Statistics
High Average Low
11.16 4.9 1.54
(Sep 30 2021)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Third Harmonic Bio Inc   51.10 $ 288.877  Millions$ 5.653  Millions
Nuvation Bio Inc   45.21 $ 595.073  Millions$ 13.161  Millions
Tyra Biosciences Inc   44.06 $ 251.213  Millions$ 5.701  Millions
Filana Therapeutics Inc   42.03 $ 201.015  Millions$ 4.783  Millions
Lexaria Bioscience Corp   40.68 $ 6.161  Millions$ 0.151  Millions
Ars Pharmaceuticals Inc   39.40 $ 274.381  Millions$ 6.964  Millions
Altimmune inc   38.48 $ 184.880  Millions$ 4.804  Millions
Cocrystal Pharma Inc   38.06 $ 37.144  Millions$ 0.976  Millions
Dice Therapeutics Inc   37.91 $ 574.225  Millions$ 15.149  Millions
Arca Biopharma Inc  37.50 $ 42.445  Millions$ 1.132  Millions
Atea Pharmaceuticals Inc   35.00 $ 646.709  Millions$ 18.478  Millions
Aprea Therapeutics Inc   34.16 $ 28.787  Millions$ 0.843  Millions
Nanoviricides inc   34.08 $ 14.070  Millions$ 0.413  Millions
Karuna Therapeutics Inc   33.11 $ 1,124.044  Millions$ 33.946  Millions
Merrimack Pharmaceuticals Inc  33.00 $ 19.439  Millions$ 0.589  Millions
Rayzebio Inc   31.88 $ 296.945  Millions$ 9.314  Millions
Xbiotech Inc   31.63 $ 217.478  Millions$ 6.875  Millions
Cohbar Inc   30.98 $ 15.737  Millions$ 0.508  Millions
Design Therapeutics Inc   30.66 $ 330.387  Millions$ 10.776  Millions
Greenwich Lifesciences Inc   30.50 $ 13.468  Millions$ 0.442  Millions
Prometheus Biosciences Inc   30.49 $ 695.752  Millions$ 22.817  Millions
Briacell Therapeutics Corp   30.42 $ 41.042  Millions$ 1.349  Millions
Tao Synergies Inc   28.55 $ 37.478  Millions$ 1.313  Millions
Eqrx Inc   28.24 $ 1,399.286  Millions$ 49.546  Millions
Cyteir Therapeutics Inc   27.68 $ 147.120  Millions$ 5.315  Millions
Minerva Neurosciences Inc   26.20 $ 36.094  Millions$ 1.378  Millions
Xenon Pharmaceuticals Inc   26.08 $ 592.087  Millions$ 22.702  Millions
Silo Pharma Inc  26.05 $ 11.367  Millions$ 0.436  Millions
Spruce Biosciences Inc   25.94 $ 79.077  Millions$ 3.048  Millions
Gh Research Plc  25.87 $ 165.955  Millions$ 6.414  Millions

Date modified: 2026-06-22T14:32:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.